Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 01, 2023	Mar. 26, 2022
OPERATING ACTIVITIES
Net income	$ 78,195	$ 124,839
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,198	13,757
Non-cash interest charges	66	112
Provisions for losses on trade and other accounts receivable	3,199	2,626
Gains on sales/disposals of operating property	(1,140)	(165)
Deferred income taxes, net	758	1,324
Stock-based compensation	1,852	1,995
Changes in operating assets and liabilities:
Decrease (increase) in trade and other accounts receivable	67,776	(93,542)
Decrease in other assets	8,625	2,531
(Decrease) increase in accounts payable	(37,068)	22,207
Increase in other liabilities	2,640	11,910
(Decrease) increase in insurance claims	(1,066)	7,371
NET CASH PROVIDED BY OPERATING ACTIVITIES	139,035	94,965
INVESTING ACTIVITIES
Sales and maturities of investments	40,349	12,420
Purchases of investments	(31,425)	(13,428)
Purchases of operating property	(6,233)	(3,609)
Proceeds from sales of operating property	1,645	643
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES	4,336	(3,974)
FINANCING ACTIVITIES
Decrease in cash overdraft	(26,758)	(20,263)
Dividends paid	(82,660)	(84,711)
Proceeds from exercises of stock options	28	56
Taxes paid in lieu of shares issued related to stock-based compensation plans	(8,236)	(10,183)
Borrowings on revolving credit facility	0	70,000
Purchases of common stock	(15,433)	(109,332)
Principal payments on finance lease obligations	(9,408)	(9,532)
NET CASH USED BY FINANCING ACTIVITIES	(142,467)	(163,965)
Effect of exchange rate changes on cash and cash equivalents	502	815
Increase (decrease) in cash, cash equivalents and restricted cash	1,406	(72,159)
Cash, cash equivalents and restricted cash at beginning of period	339,581	219,571
Cash, cash equivalents and restricted cash at end of period	$ 340,987	$ 147,412